Barclays’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2
| Closed | -$14 | – | 5206 |
|
|
2025
Q4 | $14 | Buy |
+2
| New | +$12 | ﹤0.01% | 5151 |
|
|
2025
Q3 | – | Sell |
-89
| Closed | -$422 | – | 5585 |
|
|
2025
Q2 | $395 | Sell |
89
-4,087
| -98% | -$17.1K | ﹤0.01% | 5083 |
|
|
2025
Q1 | $23.6K | Sell |
4,176
-2,040
| -33% | -$26.1K | ﹤0.01% | 4768 |
|
|
2024
Q4 | $131K | Buy |
6,216
+350
| +6% | +$8.04K | ﹤0.01% | 4513 |
|
|
2024
Q3 | $158K | Buy |
5,866
+4,415
| +304% | +$130K | ﹤0.01% | 4414 |
|
|
2024
Q2 | $41.3K | Sell |
1,451
-1,415
| -49% | -$49.6K | ﹤0.01% | 4281 |
|
|
2024
Q1 | $122K | Sell |
2,866
-2,714
| -49% | -$122K | ﹤0.01% | 4358 |
|
|
2023
Q4 | $299K | Buy |
5,580
+4,861
| +676% | +$219K | ﹤0.01% | 4209 |
|
|
2023
Q3 | $30.9K | Sell |
719
-64
| -8% | -$2.95K | ﹤0.01% | 4047 |
|
|
2023
Q2 | $43K | Buy |
+783
| New | +$43K | ﹤0.01% | 3907 |
|
|
2022
Q4 | – | Sell |
-5
| Closed | – | – | 5307 |
|
|
2022
Q3 | $0 | Buy |
+5
| New | +$165 | ﹤0.01% | 4929 |
|
|
2022
Q2 | – | Sell |
-638
| Closed | -$40K | – | 5123 |
|
|
2022
Q1 | $40K | Sell |
638
-4,131
| -87% | -$244K | ﹤0.01% | 4200 |
|
|
2021
Q4 | $337K | Buy |
4,769
+3,163
| +197% | +$225K | ﹤0.01% | 3369 |
|
|
2021
Q3 | $112K | Buy |
1,606
+1,087
| +209% | +$86.5K | ﹤0.01% | 3861 |
|
|
2021
Q2 | $44K | Sell |
519
-2,682
| -84% | -$190K | ﹤0.01% | 4188 |
|
|
2021
Q1 | $174K | Buy |
3,201
+1,634
| +104% | +$79.5K | ﹤0.01% | 3773 |
|
|
2020
Q4 | $67K | Sell |
1,567
-178
| -10% | -$6.64K | ﹤0.01% | 4297 |
|
|
2020
Q3 | $52K | Sell |
1,745
-1,469
| -46% | -$49.4K | ﹤0.01% | 4581 |
|
|
2020
Q2 | $100K | Buy |
+3,214
| New | +$86.6K | ﹤0.01% | 4515 |
|
|
2019
Q4 | – | Sell |
-3
| Closed | – | – | 6539 |
|
|
2019
Q3 | $0 | Sell |
3
-7,509
| -100% | -$187K | ﹤0.01% | 6870 |
|
|
2019
Q2 | $150K | Buy |
7,512
+6,378
| +562% | +$187K | ﹤0.01% | 5361 |
|
|
2019
Q1 | $48K | Buy |
1,134
+1,009
| +807% | +$36.6K | ﹤0.01% | 5897 |
|
|
2018
Q4 | $4K | Sell |
125
-1,486
| -92% | -$58.6K | ﹤0.01% | 6521 |
|
|
2018
Q3 | $85K | Buy |
1,611
+1,353
| +524% | +$75.9K | ﹤0.01% | 5705 |
|
|
2018
Q2 | $14K | Sell |
258
-262
| -50% | -$13.4K | ﹤0.01% | 6374 |
|
|
2018
Q1 | $26K | Buy |
+520
| New | +$23.3K | ﹤0.01% | 6317 |
|
|
2016
Q3 | – | Sell |
-285
| Closed | -$8K | – | 6689 |
|
|
2016
Q2 | $8K | Buy |
+285
| New | +$9.06K | ﹤0.01% | 5612 |
|
|
2015
Q4 | – | Sell |
-18
| Closed | -$1K | – | 6208 |
|
|
2015
Q3 | $1K | Sell |
18
-46
| -72% | -$2.14K | ﹤0.01% | 6541 |
|
|
2015
Q2 | $3K | Buy |
+64
| New | +$3.64K | ﹤0.01% | 6676 |
|
|
2014
Q4 | – | Sell |
-4
| Closed | – | – | 7404 |
|
|
2014
Q3 | $0 | Sell |
4
-1,794
| -100% | -$82.5K | ﹤0.01% | 7728 |
|
|
2014
Q2 | $72K | Buy |
1,798
+1,147
| +176% | +$48.2K | ﹤0.01% | 5680 |
|
|
2014
Q1 | $26K | Sell |
651
-320
| -33% | -$14.6K | ﹤0.01% | 6449 |
|
|
2013
Q4 | $39K | Buy |
971
+816
| +526% | +$35.6K | ﹤0.01% | 6353 |
|
|
2013
Q3 | $5K | Sell |
155
-1,605
| -91% | -$63.1K | ﹤0.01% | 6976 |
|
|
2013
Q2 | $63K | Buy |
+1,760
| New | +$67.4K | ﹤0.01% | 6144 |
|
Other funds holding HBIO
WCM
VCM
CCM
MIM
NCNMGF
